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Antimicrobial peptides (AMP’s) protect epithelial surfaces including epididymis against pathogens and play a key role in
orchestrating various defensive responses. Recently, we have identiﬁed one such AMP, rabbit epididymal hemoglobin-β subuit
(REHbβP) from the epididymal ﬂuid of rabbit, Oryctologus cuniculus. The demonstration of a protective role of REHbβPi n
epididymal epithelial cells (EPEC’s) led us to investigate: (1) the identiﬁcation of LPS interactive domain in REHbβP, and
(2) whether the REHbβP of rabbit origin mediates vaginal cellular immune responses of another species (human). HeLa-S3,
human vaginal epithelial cells (hVECs) were exposed to LPS or the LPS-stimulated cells treated with REHbβP or neutral peptide,
nREHbβP. Eﬀect of LPS and cytokines (IL-6 and IL-1α) and chemokines (IL-8, MCP-1) levels was determined in the culture
supernatants. In response to the LPS, hVECs synthesized these mediators and the levels were signiﬁcantly higher than controls.
This enhancing eﬀect was ameliorated when the LPS-induced hVECs were treated with REHbβP. Similar results were obtained
on NF-κB protein and hBD-1 mRNA expression. Confocal microscopy studies revealed that REHbβP attenuated the LPS-induced
internalizationofE.colibymacrophages.ThechemotaxisstudiesperformedusingBoydenchamberTranswellassay,whichshowed
elevatedmigrationofU937cellswhenthesupernatantsofLPS-inducedhVECswereused,andtheeﬀectwasinhibitedbyREHbβP.
REHbβP was found to be localized on the acrosome of rabbit spermatozoa, suggesting its role in sperm protection beside sperm
function.Inconclusion, REHbβPmayhave thepotential todevelop as atherapeutic agent for reproductivetract infections (RTI’s).
1.Introduction
A number pathogens can infect both male and female
reproductive tracts in humans and animals [1]. In a large
proportion of infections, products such as lipopolysaccha-
ride (LPS) and endotoxins are responsible. LPS is a major
structuralandfunctionalcomponentoftheoutermembrane
of Gram-negative bacteria [2] and exhibits a variety of
toxic and proinﬂammatory activities. Therefore, identifying
molecules that bind to LPS and neutralize its activity has
clinical applications [3, 4].
The epididymis is anatomically connected to the urethra,
so it is always at risk of ascending microbial invasion. It has
been reported that in men the penile urethra is the entry for
various STI-causing pathogens such as Neisseria gonorrhoeae
and Chlamydia trachomatis, and urethritis is the most
common clinical syndrome [5]. Infection originating from
retrograde ascent of pathogens via the ejaculatory ducts, vas
deferens, or the blood vessels supplying the epididymis is
a common cause of acute epididymitis. Epididymitis is the
most common intrascrotal inﬂammation and is a signiﬁcant
cause of urological consults [5, 6].
Epididymal epithelial cells (EPECs) form a barrier to
create a unique microenvironment in the lumen, where
interactions between EPECs and spermatozoa take place via
the ﬂuid milieu [7]. Spermatozoa binds a variety of proteins2 International Journal of Peptides
as they pass through the epididymis [8]. Beside sperm
maturation,theepididymisisknowntocontaineﬃcientself-
defense machinery to deal with microbial infections [9, 10].
Recent studies have indicated that EPECs of rats, mice, and
humanssynthesizedavarietyofmoleculeshavingantimicro-
bial activities. Some of them are Bin-1β [11], Eppin [10],
HE2-α [12], β-defensins [13], SOB3 [14], EP2/HE2 [5],
hCAP-18 [15], and cystatin-11 [16]. It has also been re-
ported that several hemoglobin- (Hb-) derived peptides of
female reproductive tract of human [17–21]a r ee ﬀective
against various sexually transmitted infections (STI’s) caus-
ing pathogens.
Our group has recently isolated one such Hb-derived
AMP,rabbitepididymalhemoglobinbetapeptide(REHbβP)
from rabbit epididymal ﬂuid [22]. REHbβP showed 96%
sequence identity with the human Hb-β subunit. The pur-
pose of the present study was to predict the LPS binding
aminoacids in the REHbβP sequence. A further purpose was
to evaluate the LPS-neutralizing activity of REHbβPb yd o c -
umenting its ability to block LPS-induced proinﬂammatory
responses by LPS-sensitive target cells in vitro.I nr e s p o n s et o
LPS induction, human vaginal epithelial cells (hVECs)
produced elevated levels of various cytokines/chemokines
(IL-8, IL-6, IL-1α, and MCP-1). This enhancing eﬀect of LPS
on these inﬂammatory biomarkers was ameliorated by the
treatment of hVECs with REHbβP.
2.MaterialandMethods
2.1. Media and Reagents. Two 29mer linear peptides
REHbβP (104–133 amino acids) and nREHbβP (13–41
amino acids) of Hb-β subunit were commercially procured
from USV Ltd., Mumbai, India. LPS-E. coli 055:B5, N-
formyl-methionyl-leucyl-phenylalanine (fMLP), and pri-
mary and secondary antibodies used in various experiments
were procured from Sigma, USA. Kits for interleukin-6 (IL-
6), interleukin-8 (IL-8), macrophage chemotactic protein-1
(MCP-1), and interleukin-1α (IL-1α) were obtained from
R&D Systems, USA. For the generation of stock solutions,
all reagents were dissolved in endotoxin-free water (Sigma,
USA).AllotherreagentswerepurchasedfromSigma-Aldrich
(St. Louis, USA) unless speciﬁed otherwise.
2.2. Human Vaginal Epithelial Cells, Macrophages, and U-937
Cells. Human vaginal epithelial cells (HeLa-S3), macro-
phages, and U-937 cells were procured from National Center
for Cell Sciences (NCCS), Pune, India, and grown in DMEM
(HeLa-S3cells)orRPMI-1640(macrophagesandU937cells)
as per the supplier’s instructions.
2.3. Structure Prediction of REHbβP and Its Docking with
LPS by Using Homology Modeling. The amino acid sequence
of Hb protein was used for the selection of the REHbβP
templatesequence.Twomaincriteriawereconsideredforthe
selection of the template: (i) the Hb protein should possess
an authenticated crystal structure and (ii) the selected
template must demonstrate maximum homology with
the Hb protein. After selecting the template by the above
criteria, Hb crystal structure was used to model the struc-
ture of REHbβP. Before this, the obtained template was
energy minimized using Swiss pdb viewer [23]t or e m o v e
steric clashes from the crystal structure by using WHATIF
server (http://swift.cmbi.ru.nl/servers/html/index.html). To
predict the overall stability, we ﬁrst determined phi-
psi angles followed by structural analysis using Raman-
chandran plot and PROSA software, respectively [24].
Finally, the template was validated with What If server
(http://swift.cmbi.ru.nl/servers/html/index.html). The pep-
tide, REHbβP and the charged LPS were docked by using
Hex 6.1 software [25]. While docking, for correlation type,
we selected shape and electrostatic parameters and 3D LITE
in FFT mode. Postprocessing was carried out using MM
minimization. Of the generated docked structures, the least
binding energy was selected. Binding interactions of the duo
was visualized using chimera software.
2.4. Design and Synthesis of Peptides (REHbβPa n d
nREHbβP). The 15mer sequence corresponding to 110–124
amino acids (LVIVLSHHFGKEFTP) of the Hb-β subunit
has been subjected to various bioinformatics tools to
identify the aminoacids that are interactive with the
LPS shown in Figure 2. A 29mer sequence correspond-
ing to 104–133 amino acids of the Hb-β subunit
(RLLGNVLVIVLSHHFGKEFTPQVQAAYQK), which con-
sists of the above 15mer sequence, has been synthesized
in circular form. To analyze the LPS binding speciﬁcity
of REHbβP, a 29mer non-LPS binding region corre-
sponding to 13–41 amino acids (ALWGKVNVEEVGGEAL-
GRLLVVYPWTQRF) of the Hb-β subunit has been syn-
thesized and named as scrambled (control) or neutral
peptide (nREHbβP), and its LPS binding and neutralizing
activity was assayed along with REHbβP. The purity of these
peptides was conﬁrmed by mass spectrometry and amino
acid analysis and found to be ∼95%.
2.5. Cell Culture and Treatment. The hVECs used in this
study constitutively expressed TLR4 and responded to the
LPS [26]. On the day of treatment, cells at 70–80%
conﬂuence were passaged. In our previous study, we have
demonstrated that LPS with concentrations of 10μg/mL did
not inhibit the viability human endocervical epithelial cells
(End1/E6E7) [27]; therefore, this dose was selected for this
study.
ThehVECswereseededatadensityof2×106 cells/wellin
24-well plates and incubated for 24h at 37◦Ci n5 %C O 2
and 95% air and divided into six groups: (1) cells grown
in culture medium for 24h without any treatment (medium
control), (2) cells treated with REHbβP (60.61μMf o r1h ) ,
(3) scrambled peptide (nREHbβP) (60.61μM for 1h), (4)
cells induced with LPS alone (10μg/mL for 6h), (5) after
washing cells treated with REHbβP (60.61μMf o r1h ) ,a n d
(6) nREHbβP (60.61μM for 1h). In addition to these six
groups, we also included an additional group for chemotaxis
experiments wherein the hVECs were treated ﬁrst with
polyclonal anti-TLR4 antibody before stimulation with LPS.
At the end of treatment, cells were washed twice with PBSInternational Journal of Peptides 3
(pH 7.4), cultured for an additional 24h, and the spent
media along with cells from control and treated groups were
collected for various studies.
2.6. ELISA to Determine REHbβP Binding to LPS. The
ability of REHbβP to bind to LPS was determined by the
method described earlier [27]. Brieﬂy, a 96-well microtiter
plate was coated with 100μLo fL P S( 5μg/mL) dissolved in
PBS and incubated for 60min with 100μL of two-fold
serially diluted peptides (1.89–60.61μM). ELISA was devel-
oped with an aﬃnity-puriﬁed rat antiserum raised against
REHbβPa n dnREHbβP, and a secondary goat anti-rat anti-
body (Sigma, USA) conjugated to horse radish peroxidase-
HRP. O-phenylenediamine (1mg/mL) was used as a sub-
strate, and the absorbance was measured at 490nm on
a microplate reader (ELX-800, Bio-Tek Instruments, and
USA). A known peptide, Scylla serrata, antilipopolysaccha-
ride factor-24 (SsALF-24) was used as positive control for
LPS binding [27].
2 . 7 .M e a su r em en to fC yt o k i n eL ev el sb yE L I S A . Biomarkers of
inﬂammation, namely, interleukin-6 (IL-6), interleukin-8
(IL-8), monocyte chemoattractant protein-1 (MCP-1), and
interleukin-1α (IL-1α) were measured in all the six groups of
culture supernatants by using commercially available human
cytokine kits with matched antibodies (R&D system, USA)
as described earlier [28]. Brieﬂy, supernatants were cleared
of cells by centrifugation at 1000×gf o r1 0m i na t4 ◦Ca n d
used for the estimation of cytokines (IL-6 and IL-1a), and
chemokines (MCP-1 and IL-8) after determining the total
protein concentration [29]. Compounds (LPS, REHbβP, and
nREHbβP) interference with cytokine detection was ruled
outbyspikingknownamountsofrecombinantIL-6andIL-8
and measuring the percentage cytokine recovery from
compound-supplemented medium versus plain medium
control.
2.8. Determination of Phospho-NF-kB p65 Levels by ELISA.
To address the question of whether REHbβPc o m p e t e dw i t h
LPS at the receptor level or it aﬀects occurred downstream
from TLR4-LPS signaling, and to accomplish this task, the
treatment protocol followed is the same as described under
cell culture and treatment in Section 2. Preincubation of
hVECs with the LPS ensured LPS-TLR binding in the
absence of REHbβP, and hVECs stimulated with LPS alone
ensured interaction between TLR4-LPS in the absence of
REHbβP. The LPS-induced cells (group-4) were treated with
REHbβP (group-5) or nREHbβP (group-6) for 1h. After the
treatment, hVECs were lysed with hypotonic HEPES lysis
buﬀer(pH7.4)andcentrifugedat1000×gfor10minat4 ◦C.
Supernatants were collected and total protein concentration
was determined [29] before estimating NF-kBl e v e l sb y
ELISA as described earlier [30].
2.9. RT-PCR Analysis of hBD-1 Gene in hVECs. To deter-
mined if LPS induces the expression of human-beta
defensin-1 (hBD1) mRNA, hVEC cells were seeded at a den-
sity of 106 per well in 6-well plates. After being washed,
cellular RNA was extracted by TRIZOL solution (Invitro-
gen) according to the manufacturer’s protocol. The primer
sequences used for hBD1 (196bp) used were sense 5 -CTC-
TGCTTGCTGCCATTCTC-3  and antisense 5 -AATCGT-
CTGCAAGTACAGGACAC-3 , and for GAPDH (199bp)
sense5 -CCATTCATTGACCTCCACTACA-3 ,antisense5 -
CGTTGCTGACAATCTTGAGAGA-3 . Products of the ex-
pected sizes were generated with and separated on a 2%
agarose gel with electrophoresis and visualized by ethidium
bromide staining under UV illumination. The gels were
scanned by using a Gel Documentation System (Gel Doc
2000, Bio-Rad Laboratories) and intensity of the bands was
quantiﬁed by “Quantity-One” software.
2.10. Mcrophage Phagocytic Assay. Gram-negative bacteria
(E. coli) were labeled with ﬂuorescein isothiocyanate (FITC)
as described earlier [17]. Macrophages (1 × 106)w e r e
stimulated with LPS (10μg/mL for 1h), washed twice with
RPMI,and treated with REHbβPo rnREHbβP (60.61μMf o r
1h). After two washings in RPMI to remove peptides, cells
were incubated at 37◦C with the cell suspensions of FITC-
labeled E. coli (ratio of macrophages: E. coli 1:20) in a total
volume of 1mL in siliconized glass tubes. Macrophages not
exposed to E. coli were handled identically to determine the
background. After 30min of incubation, 1mL of ice-
cold complete RPMI medium per mL was added and
centrifuged (110×g, 8min) to separate phagocytic cells
from free bacteria. Cells were washed twice in complete
RPMI. The internalized bacteria and surface-bound bacteria
were visualized under FITC optics using a confocal laser
scanningmicroscopeLCSM(Zeiss,510Meta,andGermany).
We included plain macrophages as appropriate negative
control to rule out any nonspeciﬁc activity. The number of
internalized labeled E. coli in the presence of REHbβPo r
nREHbβP was determined as phagocytic index (PCI). The
PCI was deﬁned as the number of bacteria-containing
macrophages per high-power ﬁeld (×63)/total number of
cellsintheﬁeld,expressedasapercentage.Forquantiﬁcation
of the PCI for a given condition, at least 25 ﬁelds were
sequentially examined.
2.11. Chemotaxis Assay. The eﬀect of REHbβP on U937
cell migration was assessed by a chemotaxis assay that used
cAMP-activated U937 cells as described earlier [31]. For this
study, cultures from all the six groups along with anti-
TLR4 group were used and the treatment protocol was
the same as discussed under cell culture and treatment.
LPS-induced cells were treated with REHbβP (15.50 and
60.61μM for 1h). Cells treated with 700mM chemotactic
peptide (N-formyl-methionyl-leucyl-phenylalanine (fMLP))
in PBS/BSA and placed in the lower chamber and considered
as a positive control for cell migration. Conditioned media
was harvested 24h later from all the treatment and control
groups and used for the inﬁltration/migration of U937 cells.
Brieﬂy, U937 cells (5 × 104 in 500μLo fs e r u m - f r e em e -
dium) were loaded into the upper chamber of the Boy-
den chamber Transwells (0.4-μM pore size polycarbonate
membranes). Lower chambers were loaded with spent media4 International Journal of Peptides
obtainedfromREHbβP, nREHbβP,andanti-TLR4antibody-
treated groups. Two concentrations of REHbβP (60.61 and
15.50μM) were added to lower chamber. The chambers were
then incubated in a humidiﬁed CO2 incubator at 37◦Cf o r
3h.NonmigratedU937cellsremainedontheupperchamber
of the insert were removed by placing the insert into a sterile
24-well plate, and cells migrating across the membrane were
ﬁxed, stained with crystal violet, and counted directly in a
phase contrast microscope (×40). The results were expressed
as the percentage of chemotaxis obtained in response to
a maximal stimulation with the fMLP chemoattractant
(100%).
2.12. Indirect Immunoﬂuorescence. The presence and distri-
bution of REHbβP on rabbit spermatozoa were analyzed
by indirect immunouorescence (IF). The spermatozoa was
collected from cauda epididymis, washed thrice in PBS, then
placed on poly-L-lysine-coated glass slides and ﬁxed 3.7%
paraformaldehyde in phosphate buﬀer (pH 7.4) for 10mm.
After washing in PBS, the nonspeciﬁc sites were blocked
with normal goat serum. Slides were incubated overnight at
4◦Cw i t hp r i m a r yR E H b βP antibody raised in rats (1/250).
Preimmuneratserawereusedasnegativecontrol.Slideswere
incubated overnight at 4◦C with FITC-labeled goat anti-rat
secondary antibody (1/1000) for 1h at room temperature.
In between each step, the slides were washed six times for
5min in blocking solution. Slides were counter stained with
propidium iodide (PI), cover slipped, and mounted with
VECTASHIELD mounting medium (Vector Labs, USA) and
visualized with a confocal laser scanning microscope-LCSM
(Zeiss, 510 Meta, Germany). Images were digitalized using
CCD digital camera and Image-Pro Express Software at the
central equipment facility of NIRRH, Mumbai.
2.13. Statistical Analysis. Data are expressed as mean and
standard error of the mean (SEM) of at least three inde-
pendent experiments. Diﬀerences between the groups were
compared by a one-way analysis of variance with post hoc
range test Bonferroni adjustment. Results were considered
statistically signiﬁcant for P<0.05.
3. Results
3.1. Structure Prediction, Synthesis, and Docking of REHbβP
with LPS. The results of the present study demonstrated
that REHbβP showed 96% sequence homology with rabbit
Hb-β subunit. Three-dimensional structure of this subunit
was used as a template for modeling REHbβPb yM o d -
eller software. Hemoglobin-β (Hb-β) subunit was docked
with LPS by using Hex 6.1 software. Interaction of rabbit
Hb-β subunit with LPS was analyzed by obtaining the
crystal structure of rabbit Hb-β protein from pdb id:
2RAO viewer. Energy was minimized and bumps were
removed by using SwissPdb viewer and Whatif serv-
er (http://swift.cmbi.ru.nl/servers/html/index.html). This
structure was docked with the LPS using Z-DOCK server
(http://zdock.bu.edu/). Overall, 2000 poses were generated,
which were ranked according to their interactions. The best
pose was selected and studied for its interactions using
molecular visualization tool, Swiss pdb viewer.
Few amino acids (∗∗∗∗∗SHHFG∗E∗∗∗) within the 110
to 124 aminoacids of Hb-β subunit showed the interaction
with LPS (Indian Patent ﬁled on 18-10-2010). The residues
showing interactions were Ser115,H i s 116,H i s 117,P h e 118,
Gly119,andGlu 121(Figure 1).TheN-terminalandC-terminal
regions formed a helical structure with a loop region in
between. Even though this short peptide comprises both
helix and loop region, the binding was conﬁned only to a
loop region with the basic residues. The negatively charged
phosphate ion showed interactions with the positively
charged residues.
3.2.REHbβPNeutralizesLPSActivity. Thepeptidesequences
synthesized are shown in Figure 2.R E H b βP is able to bind
and neutralized the LPS activity in a dose-dependent man-
ner, with a higher binding at a concentration of 60.61μM.
As expected, the scrambled peptide, nREHbβP, failed to
bind and neutralize the LPS, whereas the positive control
peptide, SsALF-24, signiﬁcantly neutralized the LPS activity
(Figure 3).
3.3. Suppressive Eﬀect of REHbβP on Chemokine/Cytokine
Production Is Dependent on Binding of REHbβPt oL P S .To
investigate whether REHbβP has any eﬀect on the LPS-
induced synthesis/release of cytokine/chemokines, we mea-
sured the inﬂammatory biomarkers using ELISA in the
culture supernatants as detailed in Section 2. LPS certainly
promoted the secretion of cytokines/chemokines in hVECs.
Figures 4(a)–4(d) illustrate signiﬁcantly increased (P<0.05)
levels of cytokines (IL-6 and IL-1α) and chemokines (IL-8
and MCP-1) of hVECs when stimulated with nontoxic
dose of LPS (10μg/mL for 6h). In sharp contrast, LPS-
induced cytokine production was dramatically suppressed
and reached the baseline level when these cells were treated
with REHbβP as compared with medium control (Figure 4).
As expected, nREHbβP did not inhibit LPS-induced trig-
gering of cytokine/chemokine production. The observed de-
crease of these mediators is not due to cytotoxicity, since
REHbβP, nREHbβP, and LPS were nontoxic in the immuno-
suppressive dose range. Known concentrations of IL-8 and
MCP-1 spikes were fully recovered (data not shown), thus
observed results are not due to the assay interference.
3.4. REHbβP Downregulates LPS-Induced NF-kBL e v e l s . The
ELISA results demonstrated that induction of hVECs by
LPS led to the upregulation of NF-kB. Interestingly, treat-
ment of hVECs with REHbβP resulted attenuation of NF-kB
activity in comparison with medium control (Figure 5).
3.5. LPS-Induced hBD1 mRNA Expression Is Inhibited by
REHbβP. To deﬁne more fully the pattern of hVEC respon-
siveness to LPS and to examine whether the increased cy-
tokine levels in hVECs were associated with any that occur
in hVEC immune protection. For this, we chose hBD-1,
(a known marker for cell protection against pathogens) and
determined its mRNA expression after LPS induction inInternational Journal of Peptides 5
S115
Q127 DPO
FTT
E121
F118
G119
H117
H116
S115
E132
{ } ∗∗∗∗ ∗ ∗∗∗
110 115 120 124
S H H F G E
(a) (b)
Figure 1: Hemoglobin-β (Hb-β) subunit docked with LPS. Few amino acids in between 110 to 124 of REHbβP showed interaction with
LPS. The residues showing interaction are: Ser115,H i s 116,H i s 117,P h e 118,G l y 119,G l u 121. The N-terminal and C-terminal region forms helical
structure with a loop region in between ((a): 3D structure of Hb-β subunit; (b): interactive amino acids of REHbβP with the LPS are
indicated).
1 VHLSSEEKSAVTALWGKVNVEEVGGEALGRLLVVYPWTQRFFESFGDLSS 50
51 ANAVMNNPKVKAHGKKVLAAFSEGLSHLADNLKGTFAKLSELHCDKLHVDP 100
101 ENFRLLGNVLVIVLSHHFGKEFTPQVQAAYQKVVAGVANALAHKYH 146
Hb-β
REHbβP
nREHbβP
∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗
Figure 2: Translation of the rabbit Hb-β subunit coding sequence. Rabbit epididymal antimicrobial protein (REAMP), a 15mer sequence
(indicated in straight line) having antibacterial activity. This sequence corresponds to the amino acids 110–124 of Hb-β subunit (blue
underline).Two29merpeptidesequencesofrabbitepididymalHb-β subunitREHbβPcorrespondingtotheaminoacids104–133(indicated
in dotted line) and nREHbβP corresponding to the amino acids 13–41 (indicated in asterisks) of Hb-β subunit were synthesized. The
nREHbβP has been considered as scrambled or control peptide.
hVECs by RT-PCR. The results revealed that hVECs ex-
pressed hBD1 mRNA. By comparing these levels with that
of GAPDH in LPS-induced hVECs, we could show hBD1
mRNA expression is upregulated by ∼50%, whereas this up-
regulation is signiﬁcantly inhibited by REHbβP( ∼24%)
(group-5) compared with the medium control (group-1)
(Figure 6).
3.6. REHbβP Downregulated LPS-Induced Phagocytosis. We
next investigated whether REHbβP modulate the LPS-
induced phagocytic activity of macrophages. As shown in
Figure 7, when the macrophages were treated with the LPS
(10μg/mL for 1h) (group-4), higher number of E. coli is
internalizedinthecytoplasmofthemacrophagesoverthatof
cells that were incubated alone either with E. coli or REHbβP
or scrambled peptide. The phagocytosis index (PCI) of
medium control is ∼1.79 ± 0.14%, P<0.05, as compared to
LPS stimulated cells (4.22 ± 0.70%). When LPS activated
macrophages treated with REHbβP (group-5), the PCI is sig-
niﬁcantly reduced (2.31±0.24%; P<0.05). As expected, the
scrambled peptide did not prevent the phagocytosis induced
by LPS.
3.7. REHbβP Attenuated LPS-Induced Migration of U937
Cells. The eﬀect of REHbβP on LPS-induced migration/in-
ﬁltration of U937 cells was investigated in vitro by using
a Boyden chamber Transwell assay. These results indicated
that inﬁltration of U937 cells was more noticeable to-
ward lower compartment containing conditioned medium
obtained from LPS-induced hVECs compared with medium
from cells that were induced with LPS followed by treatment
with REHbβP( P<0.001) and the eﬀect was dose dependent6 International Journal of Peptides
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Figure 3: Determination of REHbβP binding to the LPS by ELISA.
REHbβP bound to LPS in a dose-dependent manner. Maximum
binding was observed with 60.61μM of peptide. No binding of
nREHbβP to the LPS was observed. Values represent the mean
± S.D. of triplicate determinations performed on diﬀerent days.
Level of signiﬁcance (∗P<0.05 and ∗∗P<0.001 in compared to
nREHbβPgroup)werecalculatedbyANOVAtestfollowedbyapost
hoc Bonferroni analysis.
with a higher reduction at 60.61μM concentration. This
eﬀect was directly proportional to the concentration of
REHbβPt e s t e d .A∼12% reduction was observed with as
low as 15.50μM concentration of REHbβP, whereas the
maximum eﬀect (∼51%) was observed with 60.61μM.
Pretreatment of U937 cells with anti-TLR4 antibody before
LPS-induction signiﬁcantly suppressed the migration of
U937 cells. N-Formyl-Met-Leu-Phe was used as positive
control for U937 cell chemoattraction and was considered as
100% (Figure 8).
3.8. REHbβP Localized on the Acrosome of Rabbit Spermato-
zoa. Next,weevaluatedwhetherornotREHbβPisexpressed
by the rabbit epididymal spermatozoa. Immunoﬂuorescence
results revealed the presence of REHbβP-positive immunos-
taining on the sperm surface covering the entire acrosomal
region of the sperm. No other region of the sperm appears to
be positive for REHbβP( Figure 9).
4. Discussion
In recent years, an innate and adoptive immune function of
reproductivetracttopathogenshasgainedasigniﬁcantinter-
est among scientists. The candidate players participating in
the maintenance of epididymis homeostasis are just begin-
ning to be emerged. The epididymis is anatomically con-
nected to the urethra, hence always at risk of ascending
microbial invasion. Infection originating from retrograde
ascent of Gram-negative bacteria via the ejaculatory ducts
and the vas deferens is a common cause of acute epididymi-
tis, which sometimes leads to infertility [6].
Lipopolysaccharide (LPS) is a structural component of
theoutermembraneofnearlyallGram-negativebacteriaand
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Figure 4: (a–d) The levels of cytokines/chemokine in the super-
natants of hVECs. Cells were seeded at a density of 106/well in a 24-
well plates and treated with LPS (10μg/mL for 6h), or LPS-induced
(10μg/mL for 6h) cells were treated with REHbβP (60.61μMf o r
1h) or scrambled peptide, nREHbβP (60.61μMf o r1h ) ,a sd e t a i l e d
in Section 2. At the end of treatment, supernatants were collected
and analyzed for inﬂammatory mediators by ELISA. REHbβP
attenuated LPS-induced production of inﬂammatory mediators as
compared with the cells that were treated with scrambled peptide.
Values represent the mean ± S.D of triplicate determinations
performed on diﬀerent days. Level of signiﬁcance (∗P<0.05
compared with LPS-induced group, ∗∗P<0.05 compared with
medium control) were calculated by ANOVA test followed by a
Bonferroni analysis.International Journal of Peptides 7
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Figure 5: The levels NF-kBi nh V E Ce v a l u a t e db yE L I S A .C e l l s
were seeded at a density of 106/well in a 24-well plates and induced
with LPS (10μg/mL for 6h) or LPS-induced cells were treated
with REHbβP (60.61μMf o r1h )o rs c r a m b l e dp e p t i d enREHbβP
(60.61μM for 1h). At the end of treatment, cells were collected and
lysates were prepared and analyzed for NF-kB. Level of signiﬁcance
(∗P<0.05 compared with the LPS-induced group, ∗∗P<0.05
compared with medium control) were calculated by ANOVA test
followed by a Bonferroni analysis.
is an important protein against the permeability of bacte-
ricidal agents, including AMPs. In the present study by the
useofavarietyofbiochemicalandimmunologicapproaches,
we describe interaction of the REHbβP with the LPS and its
consequences on cellular immune responses.
By using Moeller software, the structure of REHbβPw a s
acquired. Studies suggested that the interaction between LPS
and the amphipathic loop of Hb-β subunit is of an elec-
trostatic nature whereby the positive charges of the peptide
are assumed to bind to the negative charged groups of LPS
(phosphates and carboxylates). REHbβP binds speciﬁcally to
LPS with increasing concentration. Contrary to REHbβP,
the scrambled peptide, nREHbβP did not bind to LPS,
suggesting neutralizing property of REHbβP.
Therefore, identiﬁcation of such molecules that bind and
neutralize the toxic eﬀects of pathogens may have clinical
application as a therapy for the treatment of reproductive
complications. REHbβP, identiﬁed in the rabbit epididymis,
is one such peptide belongs to the Hb family of proteins.
Recent evidence suggests that besides O2 transport, several
Hb-derivedpeptidesalsoperformdefensefunctions[19,20].
Given the diverse eﬀects of LPS signaling in the inﬂam-
mation process, we hypothesized that REHbβP intervenes in
the interaction between LPS and its surface receptor TLR4
on hVECs. The eﬀect of REHbβP on cytokine produc-
tion/releasebyhVECsinresponsetotheLPSwasinvestigated
incomparisonwiththatofthescrambledpeptide.Inﬂamma-
tory mediators were chosen as the principal end points due
to their established involvement in tissue inﬂammation, im-
munoregulation, and macrophage/neutrophil migration
[32]. REHbβP attenuated the secretion of all the four
biomarkers of inﬂammation, suggesting that inhibition in-
volves cellular events that are NF-kB independent and occur
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Figure 6: RT-PCR analysis of hBD-1 gene expression in hVECs.
Cells were seeded at a density of 106/well in a 24-well plates and
treated with LPS (10μg/mL for 6h) or LPS-induced (10μg/mL
for 6h) cells were treated with REHbβP (60.61μMf o r1 h )o r
scrambled peptide (60.61μM for 1h). At the end of treatment, cells
werecollectedandlysateswerepreparedandanalyzedforhBD1and
GAPDHmRNAsbyRT-PCRasdetailedinSection 2.(a)Expression
of hBD1 mRNA was upregulated in LPS-induced cells and atten-
uated following the treatment of LPS-induced cells with REHbβP
with respect to the scrambled peptide. Values are calculated as the
mean ± SD of triplicate determinations. Representative image of
RT-PCR analysis of hBD-1 mRNAs expression is shown. GAPDH
blots conﬁrmed roughly equivalent loading of RNA samples. (b)
A quantitative assessment of the intensity of the each band was
determined by densitometry. Levels of signiﬁcance (∗P<0.001
compared with LPS-induced groups, ∗∗P<0.001 compared with
medium control) were calculated by ANOVA test followed by a
Bonferroni analysis.
downstream from NF-kB gene transactivation. Similar
inhibitory eﬀect of crab hemolymph derived peptide, SsALF-
24 on cytokine/chemokine levels has been reported recently
[30].
The above ﬁndings raise the important question of how
REHbβP acts after the LPS has interacted with its receptor
TLR4 on hVECs and inhibits LPS-induced biomarkers of
inﬂammation. These unexpected results prompted us to
speculate on the alternative mechanisms of REHbβP-me-
diated protection unrelated to the LPS binding to TLR4. One
possiblereasonisthatLPS-TLR4interactionmayactivatecell
surface receptors other than TLR4 through which REHbβP
may exert its eﬀects or such an interaction may facilitate8 International Journal of Peptides
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Figure 7:MacrophageswheninducedwithLPS,phagocytosisindex
(PCI) was signiﬁcantly upregulated over that of cells that were
incubatedaloneeitherwithE.coliorREHbβPorscrambledpeptide.
LPS-induced macrophages treated with REHbβP (60.61μMf o r
1h) the number of E. coli internalized within macrophages was
signiﬁcantly reduced. Levels of signiﬁcance (∗P<0.001 compared
with the LPS-induced group, ∗∗P<0.001 compared with
nREHbβP group) were calculated by ANOVA test followed by a
Bonferroni analysis.
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Figure 8: Determination of U937 cell migration/inﬁltration using
chemotaxis assay. Culture supernatants of hVECs were collected
after the cells were stimulated with LPS (10μgf o r1h ) .W h e nt h e s e
supernatants were placed in the lower Transwell chamber, U937 cell
migration from upper Transwell was signiﬁcantly increased over
that of medium control. When supernatants obtained from LPS-
induced cells that were treated with REHbβP (60.61 or 15.50μM
for 1h) and used in the lower Transwell chamber, the migration
of U937 cells was reduced in a dose-dependent manner. REHbβP
at a concentration of 60.61μM resulted higher inhibition of cell
migration. As expected scrambled peptide did not suppress LPS-
induced inﬁltration of U937 cell. The data was normalized to U937
chemotaxis in response to 0.1mM fMLP in PBS/BSA, which was
used to stimulate cell migration (100%). Each value is the mean ±
S.D.ofsixindividualobservationsobtainedfromthreeindependent
experiments. Levels of signiﬁcance (∗P<0.05 compared with the
LPS-induced group, ∗∗P<0.001 compared with the LPS-induced
group, ∗∗∗P<0.001 compared with the medium control) were
calculated by ANOVA test followed by a Bonferroni analysis.
the transfer of REHbβP signals intracellularly, and thereby
inhibit synthesis/release of cytokines/chemokines. However,
at present, it is not known the cellular targets for REHbβP
and is the subject of current investigation in our laboratory.
Recently,inanelegantstudy,Duetal.[19]havereportedthat
Hb-derived peptides possess dual action centers, LPS recog-
nition, and a peroxidase cycle (POX) activity sites. The latter
produces reactive oxygen species (ROS), which recognize the
LPS and neutralize it. REHbβP is one such Hb-derived AMP
and perform similar functions.
In the epididymis, a number of cell types contribute to
the local environment and secrete an array of AMPs,
which protect spermatozoa during their epididymal transit.
However, it is not known whether REHbβP perform similar
function of sperm protection during maturation in the epi-
didymis. To know this, one of the known epididymal AMPs,
β-deﬁnsin-1 mRNA expression was determined and found
signiﬁcantly elevated after the induction of hVECs with
LPS. Interestingly, REHbβP caused a signiﬁcant blunting of
LPS-induced activation of hBD-1 mRNA, attributing anti-
inﬂammatory activity of REHbβP. These results were in
agreement with previous report, where it was shown the
upregulation of several AMPs of the defensins family by LPS
both at mRNA and protein levels [6].
In view of the above observations, studies were further
extended, which demonstrated the involvement of REHbβP
in macrophage phagocytosis. It has been reported that rec-
ognition of bacteria by host cells depends on the receptor-
ligand interaction. Upon recognition of pathogens, TLR4-
LPS complex can transfer the signal into the host cell
[33]. The present observations reveal that REHbβP inhibit
phagocytosis of E. coli by inhibiting the LPS -TLR4 inter-
actions. REHbβP, is a nonmyeloid cell-derived protein, its
involvement in host defense has not been demonstrated
previously. To our knowledge, this is the ﬁrst report to
document a potential role for REHbβP in cellular immune
responses in vitro. Besides, we also demonstrated that the
culture supernatants of LPS-induced hVECs show enhanced
chemotaxis of U937 cells. In contrast, LPS-stimulated cells
treated with REHbβP led to the inhibition of LPS-induced
migration of U937 cell in a dose-dependant manner, con-
ﬁrming once again a protective role for REHbβP on hVECs.
Further, we analyzed whether REHbβPi sp r e s e n to n
the spermatozoa. The immunoﬂuorescence revealed that
REHbβP appears as a coat covering the acrosomal region of
sperm head in rabbits. The localization suggests that
REHbβP might be involved in some process of sperm
maturation besides its antibacterial function. Cao et al. [6]
have reported that rat caput epididymal-speciﬁc β-defensin
peptide; Bin-1β plays dual roles in antibacterial and sperm
motility. However, the exact role of REHbβP in sperm capac-
itation, acrosomal induction, sperm-egg recognition and
binding is currently under investigation in our laboratory.
Inconclusion,theaforementionedstudiesstronglyreveal
thatREHbβPiscapableofprotectingepididymalspermfrom
pathogen-mediated insults. The expression pattern of
REHbβP on rabbit spermatozoa implies complex biological
functions beyond the immunoregulation. In pathological
condition of epididymis like epididymitis, clarifying howInternational Journal of Peptides 9
(a) (b) (c)
Figure 9: Images showing the immunolocalization of REHbβP on rabbit epididymal spermatozoa (Mag × 100; a–c) ((a): FITC; (b): PI,
FITC merge and (c): preimmune serum control). REHbβP localized as a coat on the acrosome of sperm heads. The ﬁgures shown are the
representative pictures from three independent experiments.
pathogens regulate the expression of REHbβP is another
interesting line of inquiry. These studies will aid in identi-
fying therapeutic targets for the prevention and treatment of
reproductive tract infections (RTIs).
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